Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Lilly Ascends to Top Pharma Company by Revenue in FY2025, Fueled by Mounjaro and Zepbound’s Explosive Growth
Laboratory Automation & Robotics

Lilly Ascends to Top Pharma Company by Revenue in FY2025, Fueled by Mounjaro and Zepbound’s Explosive Growth

Lana Keisha Apr 19, 2026 0

Eli Lilly and Company has officially claimed the top position in the global pharmaceutical industry by revenue for fiscal year…

Read More
Stem Cell & Regenerative Medicine

Explosive Growth and Evolutionary Timelines of Chronic Myeloid Leukemia Revealed Through Genomic Mapping

Dwi Wanna Apr 11, 2026 0

A groundbreaking study led by researchers at the Wellcome Sanger Institute has fundamentally altered the scientific understanding of chronic myeloid…

Read More
Stem Cell & Regenerative Medicine

New Research Unveils the Pre-Diagnostic Timeline and Explosive Growth Rates of Chronic Myeloid Leukemia

Dwi Wanna Apr 4, 2026 0

A groundbreaking study led by researchers at the Wellcome Sanger Institute has fundamentally altered the scientific understanding of how chronic…

Read More
Stem Cell & Regenerative Medicine

New Genomic Research Unveils the Rapid Evolutionary Timeline and Explosive Growth Rates of Chronic Myeloid Leukemia

Dwi Wanna Mar 20, 2026 0

In a landmark study published in the journal Nature, researchers from the Wellcome Sanger Institute and their international collaborators have…

Read More

Posts pagination

1 2
Industry Innovators to Reveal High-Performance Strategies at 31st Annual Executive War CollegeTWiV 1289: Building a better hepatitis B trapEli Lilly’s Foundayo Secures FDA Approval, Challenging Novo Nordisk’s Oral Obesity Drug DominanceReal-Time Observation of Metal-Induced Protein Clumping Offers New Pathways for Alzheimer’s Treatment Strategies
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ